Event Brief
AbbVie to buy Apogee Therapeutics for $10.9B
Filed: Jun 22, 2026 at 7:06 PM ET
Summary: AbbVie agreed to acquire Apogee Therapeutics for $10.9 billion, a 49% premium over its June 18 close.
WHO: AbbVie
WHAT: Agreed to buy Apogee Therapeutics for $10.9 billion per $135.11 a share
WHEN: Jun 22, 2026 at 5:20 PM ET
WHERE: USA
WHY: To fund the acquisition with debt and pay a roughly 49% premium over Apogee’s June 18 closing price
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →